This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Feringa, H. H.H. Articles by Poldermans, D. Search for Related Content PubMed PubMed Citation Articles by Feringa, H. H.H. Articles by Poldermans, D.

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease

Harm H.H. Feringa, MD^_*, Virginie H. van Waning, MD^_*, Jeroen J. Bax, MD, PhD, Abdou Elhendy, MD, PhD^||, Eric Boersma, PhD, Olaf Schouten, MD, Wael Galal, MD^_*, Radosav V. Vidakovic, MD^||, Marco J. Tangelder, MD, PhD and Don Poldermans, MD, PhD^_*,_*

^_* Department of Anesthesiology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands
Vascular Surgery, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Cardiology, Leiden University Medical Centre, Leiden, the Netherlands
^|| Internal Medicine, Section of Cardiology, University of Nebraska, Omaha, Nebraska

View larger version (27K): [in a new window]   Figure 1 The prescription of statins, beta-blockers, aspirins, and angiotensin-converting enzyme (ACE) inhibitors in patients who were included in different periods of time.